Obesity Week 2016 Annual Meeting

J Diabetes. 2017 Mar;9(3):215-218. doi: 10.1111/1753-0407.12509.
No abstract available

Publication types

  • News

MeSH terms

  • Benzhydryl Compounds / therapeutic use*
  • Cardiovascular Diseases / complications
  • Cardiovascular Diseases / prevention & control
  • Congresses as Topic
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Glucosides / therapeutic use*
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Liraglutide / therapeutic use*
  • Prediabetic State / physiopathology
  • Prediabetic State / prevention & control*
  • Quality of Life
  • Treatment Outcome
  • Weight Loss / drug effects*

Substances

  • Benzhydryl Compounds
  • Glucosides
  • Hypoglycemic Agents
  • Liraglutide
  • empagliflozin